Fifty-four dogs with primary tumors of the rib were evaluated. Thirty-
four dogs had osteosarcomas, 15 dogs had chondrosarcomas, three dogs h
ad hemangiosarcomas, and two dogs had fibrosarcomas. Forty-nine dogs h
ad en bloc excision. Within the osteosarcoma group, nine animals recei
ved postoperative adjuvant chemotherapy These animals had significantl
y longer median disease-free intervals (225 days) and median survival
times (240 days) than dogs with osteosarcoma treated by surgery alone
(median disease-free interval, 60 days; median survival, 90 days). Cho
ndrosarcoma had a better prognosis (median disease-free interval, 1,08
0 days, median survival, 1,080 days) than osteosarcoma, hemangiosarcom
a, or fibrosarcoma of the rib. Age, weight, sex, number of ribs resect
ed, tumor volume, and total cisplatin dose did not influence survival
nor disease-free interval.